| 000 | 01801 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517044105.0 | ||
| 264 | 0 | _c20160712 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/eye.2015.142 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDo, D V | |
| 245 | 0 | 0 |
_aMonth-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose). _h[electronic resource] |
| 260 |
_bEye (London, England) _cDec 2015 |
||
| 300 |
_a1538-44 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xdiagnosis |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntravitreal Injections |
| 650 | 0 | 4 |
_aMacular Edema _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRanibizumab _xadministration & dosage |
| 650 | 0 | 4 |
_aRetina _xpathology |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aSepah, Y J | |
| 700 | 1 | _aBoyer, D | |
| 700 | 1 | _aCallanan, D | |
| 700 | 1 | _aGallemore, R | |
| 700 | 1 | _aBennett, M | |
| 700 | 1 | _aMarcus, D M | |
| 700 | 1 | _aHalperin, L | |
| 700 | 1 | _aSadiq, M A | |
| 700 | 1 | _aRajagopalan, N | |
| 700 | 1 | _aCampochiaro, P A | |
| 700 | 1 | _aNguyen, Q D | |
| 773 | 0 |
_tEye (London, England) _gvol. 29 _gno. 12 _gp. 1538-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/eye.2015.142 _zAvailable from publisher's website |
| 999 |
_c25125692 _d25125692 |
||